The clinical potential for koff-rate measurement in adoptive immunotherapy
- PMID: 24215403
- DOI: 10.1586/1744666X.2013.855609
The clinical potential for koff-rate measurement in adoptive immunotherapy
Similar articles
-
Chimeric T cells for adoptive immunotherapy of cancer: using what have we learned to plan for the future.Immunotherapy. 2009 Nov;1(6):905-12. doi: 10.2217/imt.09.69. Immunotherapy. 2009. PMID: 20635906 No abstract available.
-
Adoptive immunotherapy: new ways to skin the cat?Clin Immunol. 2005 Nov;117(2):101-3. doi: 10.1016/j.clim.2005.08.013. Clin Immunol. 2005. PMID: 16214079 Review. No abstract available.
-
Of chimeric antigen receptors and antibodies: OX40 and 41BB costimulation sharpen up T cell-based immunotherapy of cancer.Immunotherapy. 2013 Jul;5(7):677-81. doi: 10.2217/imt.13.54. Immunotherapy. 2013. PMID: 23829616 No abstract available.
-
Making and circumventing tolerance to cancer.Eur J Immunol. 2009 Sep;39(9):2345-53. doi: 10.1002/eji.200939612. Eur J Immunol. 2009. PMID: 19634191
-
Modified T-cell receptor ligands: moving beyond a strict occupancy model for T-cell activation by antigen.Chem Immunol. 1995;60:79-99. Chem Immunol. 1995. PMID: 7857530 Review. No abstract available.
Cited by
-
Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?J Immunother Cancer. 2022 May;10(5):e003487. doi: 10.1136/jitc-2021-003487. J Immunother Cancer. 2022. PMID: 35577501 Free PMC article. Review.
-
Cytomegalovirus immune evasion sets the functional avidity threshold for protection by CD8 T cells.Med Microbiol Immunol. 2023 Apr;212(2):153-163. doi: 10.1007/s00430-022-00733-w. Epub 2022 Apr 1. Med Microbiol Immunol. 2023. PMID: 35364731 Free PMC article. Review.
-
TCR Redirected T Cells for Cancer Treatment: Achievements, Hurdles, and Goals.Front Immunol. 2020 Sep 3;11:1689. doi: 10.3389/fimmu.2020.01689. eCollection 2020. Front Immunol. 2020. PMID: 33013822 Free PMC article. Review.
-
Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection.Nat Immunol. 2020 Apr;21(4):434-441. doi: 10.1038/s41590-020-0628-2. Epub 2020 Mar 16. Nat Immunol. 2020. PMID: 32205883
-
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.Front Immunol. 2015 Nov 18;6:582. doi: 10.3389/fimmu.2015.00582. eCollection 2015. Front Immunol. 2015. PMID: 26635796 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources